KAYLEE MONDRICK: Open Payments
NPI 1972249175 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 70 payments from 12 companies in 2025. Trend: 2023 $1,033 · 2024 $774 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $315 |
| ABBVIE INC. | 19 | $161 |
| Alkermes, Inc. | 6 | $116 |
| Lundbeck LLC | 5 | $101 |
| Corium, LLC | 9 | $96 |
| Collegium Pharmaceutical, Inc. | 5 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, Azstarys, Jornay PM, SPRAVATO, FANAPT.
Industry payments across LA — which companies pay providers there.
